Manasi Sinha Jaiman, MD, MPH

Previously she was an attending physician at Harvard Medical School and Massachusetts General Hospital, where she was responsible for clinical care of pediatric endocrinology patients, including those with diabetes and metabolic disease. She also served as co-investigator for several trials developing the bionic pancreas at Massachusetts General Hospital. Dr. Jaiman received her M.D. from Medical University of South Carolina and M.P.H. from Tulane University School of Public Health and Tropical Medicine. She completed her pediatric residency at Dartmouth-Hitchcock Medical Center and endocrinology fellowship at Massachusetts General Hospital, with a focus on type 1 diabetes research.  

As a global, mission-driven Chief Medical Officer and Senior Executive, Dr. Manasi Jaiman advances breakthrough therapies through the integration of medicine and technology drawing from 15 years of clinical development, device development, regulatory filings, direct patient care, and scientific research.

Dr. Jaiman is the Chief Medical Officer at Aardvark Therapeutics.  Prior to joining Aardvark, Dr. Jaiman was Vice President at Vertex Pharmaceuticals and Chief Medical Officer of ViaCyte, where she developed several novel approaches in cell therapy in diabetes.